EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 22 / No 5 (Mai 2006) Med Sci (Paris), 22 5 (2006) 537-543 References
Free Access
Issue
Med Sci (Paris)
Volume 22, Number 5, Mai 2006
Page(s) 537 - 543
Section M/S revues
DOI https://doi.org/10.1051/medsci/2006225537
Published online 15 May 2006
  1. Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 1998; 38 : 289–319. [Google Scholar]
  2. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005; 308 : 512–7. [Google Scholar]
  3. Metaye T, Gibelin H, Perdrisot R, Kraimps JL. Pathophysiological roles of G-protein-coupled receptor kinases. Cell Signal 2005; 17 : 917–28. [Google Scholar]
  4. Chen J, Simon MI, Matthes MT, et al. Increased susceptibility to light damage in an arrestin knockout mouse model of Oguchi disease (stationary night blindness). Invest Ophthalmol Vis Sci 1999; 40 : 2978–82. [Google Scholar]
  5. Chen CK, Burns ME, Spencer M, et al.Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc Natl Acad Sci USA 1999; 96 : 3718–22. [Google Scholar]
  6. Fuchs S, Nakazawa M, Maw M, et al.A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet 1995; 10 : 360–2. [Google Scholar]
  7. Yamamoto S, Sippel KC, Berson EL, Dryja TP. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet 1997; 15 : 175–8. [Google Scholar]
  8. Ungerer M, Bohm M, Elce JS, et al.Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 1993; 87 : 454–63. [Google Scholar]
  9. Gros R, Benovic JL, Tan CM, Feldman RD. G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest 1997; 99 : 2087–93. [Google Scholar]
  10. Mak JC, Chuang TT, Harris CA, Barnes PJ. Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung. Eur J Pharmacol 2002; 436 : 165–72. [Google Scholar]
  11. Eckhart AD, Ozaki T, Tevaearai H, et al.Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol 2002; 61 : 749–58. [Google Scholar]
  12. Dinudon A, Fotia AB, Lefkowitz RJ, et al.The kinase GRK2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na+ channels. Proc Natl Acad Sci USA 2004; 101 : 11886–90. [Google Scholar]
  13. Lombardi MS, Kavelaars A, Schedlowski M, et al.Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J 1999; 13 : 715–25. [Google Scholar]
  14. Lombardi MS, Kavelaars A, Cobelens PM, et al.Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol 2001; 166 : 1635–40. [Google Scholar]
  15. Vroon A, Heijnen CJ, Lombardi MS, et al.Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J Leukoc Biol 204; 75 : 901–9. [Google Scholar]
  16. Vroon A, Heijnen CJ, Raatgever R, et al.GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo. J Leukoc Biol 2004; 75 : 698–704. [Google Scholar]
  17. Felder RA, Sanada H, Xu J, et al.G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002; 99 : 3872–7. [Google Scholar]
  18. Speirs HJ, Katyk K, Kumar NN, et al.Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004; 22 : 931–6. [Google Scholar]
  19. Bezard E, Gross CE, Qin L, et al.L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. Neurobiol Dis 2005; 18 : 323–35. [Google Scholar]
  20. Garcia-Sevilla JA, Escriba PV, Ozaita A, et al.Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J Neurochem 1999; 72 : 282–91. [Google Scholar]
  21. Grange-Midroit M, Garcia-Sevilla JA, Ferrer-Alcon M, et al.Regulation of GRK 2 and 6, beta-arrestin-2 and associated proteins in the prefrontal cortex of drug-free and antidepressant drug-treated subjects with major depression. Brain Res Mol Brain Res 2003; 111 : 31–41. [Google Scholar]
  22. Avissar S, Matuzany-Ruban A, Tzukert K, Schreiber G. Beta-arrestin-1 levels : reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. Am J Psychiatry 2004; 161 : 2066–72. [Google Scholar]
  23. Matuzany-Ruban A, Avissar S, Schreiber G. Dynamics of beta-arrestin1 protein and mRNA levels elevation by antidepressants in mononuclear leukocytes of patients with depression. J Affect Disord 2005; 88 : 307–12. [Google Scholar]
  24. Ferrer-Alcon M, La Harpe R, Garcia-Sevilla JA. Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts. Brain Res Mol Brain Res 2004; 121 : 114–22. [Google Scholar]
  25. Bohn LM, Gainetdinov RR, Lin FT, et al.Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 2000; 408 : 720–3. [Google Scholar]
  26. Terman GW, Jin W, Cheong YP, et al.G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br J Pharmacol 2004; 141 : 55–64. [Google Scholar]
  27. Xu M, Petraschka M, McLaughlin JP, et al.Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci 2004; 24 : 4576–84. [Google Scholar]
  28. King DW, Steinmetz R, Wagoner HA, et al.Differential expression of GRK isoforms in nonmalignant and malignant human granulosa cells. Endocrine 2003; 22 : 135–42. [Google Scholar]
  29. Metaye T, Menet E, Guilhot J, Kraimps JL. Expression and activity of G protein-coupled receptor kinases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2002; 87 : 3279–86. [Google Scholar]
  30. Iacovelli L, Capobianco L, D’Ancona GM, et al.Regulation of lysophosphatidic acid receptor-stimulated response by G-protein-coupled receptor kinase-2 and beta-arrestin1 in FRTL-5 rat thyroid cells. J Endocrinol 2002; 174 : 103–10. [Google Scholar]
  31. Bookout AL, Finney AE, Guo R, et al.Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth. J Biol Chem 2003; 278 : 37569–73. [Google Scholar]
  32. Voigt C, Holzapfel H-P, Paschke R. Expression of b-arrestins in toxic and cold thyroid nodules. FEBS Lett 2000; 486 : 208–12. [Google Scholar]
  33. Rockman HA, Chien KR, Choi DJ, et al.Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci USA 1998; 95 : 7000–5. [Google Scholar]
  34. White DC, Hata JA, Shah AS, et al. Preservation of myocardial b-edrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci USA 2000; 97 : 5428–33. [Google Scholar]
  35. Vroon A, Kavelaars A, Limmroth V, et al.G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 2005; 174 : 4400–6. [Google Scholar]
  36. Anis Y, Leshem O, Reuveni H, et al.Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia 2004; 47 : 1232–44. [Google Scholar]
  37. Walker JK, Fong AM, Lawson BL, et al.Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest 2003; 112 : 566–74. [Google Scholar]
  38. Fong AM, Premont RT, Richardson RM, et al.Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci USA 2002; 99 : 7478–83. [Google Scholar]
  39. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 2002; 277 : 49212–9. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.